ABOS financials

Acumen Pharmaceuticals (ABOS) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

ABOS income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$123.83M-$121.33M-2.00
2024––-$114.02M-$102.33M-1.71
2023––-$61.14M-$52.37M-1.08
2022––-$45.24M-$42.86M-1.06
2021––-$19.58M-$100.61M-5.02
2020––-$7.91M-$7.33M-17.48